0001474064-13-000027.txt : 20130211
0001474064-13-000027.hdr.sgml : 20130211
20130211164615
ACCESSION NUMBER: 0001474064-13-000027
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130207
FILED AS OF DATE: 20130211
DATE AS OF CHANGE: 20130211
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NPS PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000890465
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 870439579
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 550 HILLS DRIVE
CITY: BEDMINSTER
STATE: NJ
ZIP: 07921
BUSINESS PHONE: (908) 450-5300
MAIL ADDRESS:
STREET 1: 550 HILLS DRIVE
CITY: BEDMINSTER
STATE: NJ
ZIP: 07921
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BESHAR LUKE M
CENTRAL INDEX KEY: 0001192128
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-23272
FILM NUMBER: 13592360
MAIL ADDRESS:
STREET 1: 550 HILLS DRIVE
STREET 2: 3RD FLOOR
CITY: BEDMINSTER
STATE: NJ
ZIP: 07921
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2013-02-07
0000890465
NPS PHARMACEUTICALS INC
NPSP
0001192128
BESHAR LUKE M
550 HILLS DRIVE
BEDMINSTER
NJ
07921
0
1
0
0
EVP & CFO
Common stock
2013-02-07
4
J
0
8966
A
49539
D
Common stock
2013-02-07
4
F
0
3489
8.61
D
46050
D
Shares acquired upon vesting of restricted stock units granted to the Reporting Person on February 7, 2012 and reported on a Form 4 filed on February 9, 2012.
The Reporting Person reported all restricted stock units granted to the Reporting Person on February 7, 2012 in Table I of the Form 4 filed on February 9, 2012. As such, no adjustment to the Reporting Person's beneficial ownership needs to be made to reflect this vesting event.
Shares were withheld from the Reporting Person, in an exempt transaction under Rule 16b-3, solely to satisfy tax obligations arising from the vesting of the restricted stock described in this Form 4.
/s/ Luke Beshar, by Edward Stratemeier as attorney-in-fact
2013-02-11